210 related articles for article (PubMed ID: 37573343)
1. Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses.
Hurník P; Putnová BM; Ševčíková T; Hrubá E; Putnová I; Škarda J; Havel M; Res O; Cvek J; Buchtová M; Štembírek J
BMC Oral Health; 2023 Aug; 23(1):563. PubMed ID: 37573343
[TBL] [Abstract][Full Text] [Related]
2. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology.
Brunner P; Bihl M; Jundt G; Baumhoer D; Hoeller S
Oral Oncol; 2015 Oct; 51(10):e77-8. PubMed ID: 26306423
[No Abstract] [Full Text] [Related]
3. BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type.
Oh KY; Kim JH; Cho SD; Yoon HJ; Lee JI; Hong SD
Genes Chromosomes Cancer; 2022 Aug; 61(8):481-490. PubMed ID: 35353428
[TBL] [Abstract][Full Text] [Related]
4. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.
Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS
Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of odontogenic cysts and tumours.
Gomes IP; Bastos VC; Guimarães LM; Gomes CC
J Oral Pathol Med; 2023 Apr; 52(4):351-356. PubMed ID: 36629457
[TBL] [Abstract][Full Text] [Related]
6. DNA content and clinicopathological features aid in distinguishing ameloblastic carcinoma from ameloblastoma.
Penafort PVM; Rocha AC; Mariano FV; Dos Santos JN; Oliveira MC; Vargas PA; Sperandio M
J Oral Pathol Med; 2024 Jan; 53(1):70-78. PubMed ID: 38163857
[TBL] [Abstract][Full Text] [Related]
7. Ameloblastic carcinoma developing in preexisting ameloblastoma with a mutation of the p53 gene: a case report.
Nobusawa A; Sano T; Yokoo S; Oyama T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):e146-50. PubMed ID: 24906942
[TBL] [Abstract][Full Text] [Related]
8. [BRAF V600E expression in ameloblastomas, ameloblastic carcinomas and cysts].
Pei J; Zhang L; Jia YX; Chen WH
Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):630-634. PubMed ID: 38494972
[TBL] [Abstract][Full Text] [Related]
9. Ameloblastic fibrosarcoma: clinicopathological and molecular analysis of seven cases highlighting frequent BRAF and occasional NRAS mutations.
Agaimy A; Skalova A; Franchi A; Alshagroud R; Gill AJ; Stoehr R; Baumhoer D; Bauer S
Histopathology; 2020 May; 76(6):814-821. PubMed ID: 31899815
[TBL] [Abstract][Full Text] [Related]
10. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma.
Pereira NB; Pereira KM; Coura BP; Diniz MG; de Castro WH; Gomes CC; Gomez RS
J Oral Pathol Med; 2016 Nov; 45(10):780-785. PubMed ID: 27084044
[TBL] [Abstract][Full Text] [Related]
11. The importance of BRAF-V600E mutation to ameloblastoma metabolism.
Duarte-Andrade FF; Silva AMB; Vitório JG; Canuto GAB; Costa SFS; Diniz MG; Fernandes AP; de Toledo JS; André LC; Gomes CC; Gomez RS; Fonseca FP
J Oral Pathol Med; 2019 Apr; 48(4):307-314. PubMed ID: 30739334
[TBL] [Abstract][Full Text] [Related]
12. BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice.
Sant'Ana MSP; Dos Santos Costa SF; da Silva MP; Martins-Chaves RR; Pereira TDSF; de Oliveira EM; Martínez Pedraza R; de Castro WH; Gomes CC; Gomez RS; Fonseca FP
J Oral Pathol Med; 2021 May; 50(5):478-484. PubMed ID: 33377543
[TBL] [Abstract][Full Text] [Related]
13. Genetic Study of
Kokubun K; Yamamoto K; Akashi Y; Chujo T; Nakajima K; Matsuzaka K
Int J Surg Pathol; 2022 Jun; 30(4):378-384. PubMed ID: 34994576
[No Abstract] [Full Text] [Related]
14. Discrepancy between immunohistochemistry and sequencing for BRAF V600E in odontogenic tumours: Comparative analysis of two VE1 antibodies.
Oh KY; Cho SD; Yoon HJ; Lee JI; Hong SD
J Oral Pathol Med; 2021 Jan; 50(1):85-91. PubMed ID: 32939809
[TBL] [Abstract][Full Text] [Related]
15. Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors.
Coura BP; Dos Santos JN; Fonseca FP; Bernardes VF; de Aquino SN; Jorge Júnior J; Vargas PA; Romañach MJ; de Andrade BAB; Gomez RS; Gomes CC
J Oral Pathol Med; 2021 Nov; 50(10):1067-1071. PubMed ID: 34549835
[TBL] [Abstract][Full Text] [Related]
16. Ameloblastic carcinoma: a clinicopathologic analysis of cases seen in a Nigerian Teaching Hospital and review of literature.
Soyele OO; Adebiyi KE; Adesina OM; Ladeji AM; Aborisade A; Olatunji A; Adeola HA
Pan Afr Med J; 2018; 31():208. PubMed ID: 31497184
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of p16 tumor-suppressor gene in ameloblastic carcinoma, ameloblastoma, and dental follicles.
Khojasteh A; Khodayari A; Rahimi F; Ghaderian MH; Jafarian M; Nayebi A; Akbarzadeh Najar R; Tabatabayipanah A; Jahangirnia A
J Oral Maxillofac Surg; 2013 Jan; 71(1):62-5. PubMed ID: 22705216
[TBL] [Abstract][Full Text] [Related]
18. Adenoid Ameloblastoma with BRAF p.V600E Mutation Revealing Ameloblastomatous Origin: A First Case Report.
Noda Y; Sawada S; Sakagami T; Kojima Y; Higasa K; Tsuta K
Head Neck Pathol; 2023 Sep; 17(3):788-792. PubMed ID: 37093491
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnostics in odontogenic tumors.
Buettner R; Gültekin SE
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):81-85. PubMed ID: 36378285
[TBL] [Abstract][Full Text] [Related]
20. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts.
Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]